Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/20/2003WO2003094828A2 Cancer vaccines and methods of using the same
11/20/2003WO2003072016A3 Pharmaceutical compositions in particulate form
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049772A3 Guanidinium transport reagents and conjugates
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003041647A3 Synthesis and purification of valacyclovir
11/20/2003WO2003040399A3 Therapeutic methods for nucleic acid delivery vehicles
11/20/2003WO2003028665A3 Methods for the purification of levofloxacin
11/20/2003WO2003028664A3 Preparation of levofloxacin and forms thereof
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003024357A3 Microfabricated nanopore device for sustained release of therapeutic agent
11/20/2003WO2003023041A3 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003014105A9 Bicyclic compound, production and use as hiv inhibitors
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2002103026A3 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002085310A3 Antibiotics aa-896
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002062368A8 Method of inducing a ctl response
11/20/2003WO2002062362A3 Antiviral and antibacterial composition
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002057408A8 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
11/20/2003WO2002053189A3 Immunogenic complex
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002033050A8 Methods and compositions for promoting the maturation of monocytes
11/20/2003WO2002002055A3 Antifungal compounds and methods of use
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216555 Processes for preparing clarithromycin polymorphs
11/20/2003US20030216549 Comprises modified chemokine for use as antiinflammatory, viricidal or antiallergenic agent
11/20/2003US20030216546 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
11/20/2003US20030216479 Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof
11/20/2003US20030216475 Pharmaceutical composition
11/20/2003US20030216453 Thiazolidine derivatives and its use as antifungal agent
11/20/2003US20030216447 Compositions and method for treating infection in cattle and swine
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216438 Antimicrobial agent
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216430 3, 4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/20/2003US20030216373 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/20/2003US20030216372 Inhibitors of serine and metallo-beta-lactamases
11/20/2003US20030216369 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
11/20/2003US20030216368 Hormone replacement therapy
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216343 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216342 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216340 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
11/20/2003US20030216338 Bacteriophage having multiple host range
11/20/2003US20030216331 Micelles
11/20/2003US20030216330 Especially for methicillin or vancomycin resistant Staphylococcus aureus, vancomycin resistant Enterococci or glycopeptide-intermediate Staphylococcus aureus
11/20/2003US20030216328 Androgen derivatives and uses thereof
11/20/2003US20030216325 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
11/20/2003US20030216315 Modulation of immune response by non-peptide binding stress response polypeptides
11/20/2003US20030216307 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215797 Vaccines and immunotherapeutics derived from the human immunodeficiency virus ( HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics
11/20/2003US20030215465 Use of conjugated acid derivatives
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003US20030215436 Anitmicrobial polymer conjugates
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003CA2511749A1 Surface treatment of sars-infected lung
11/20/2003CA2485999A1 Mucosal combination vaccines for bacterial meningitis
11/20/2003CA2485992A1 Mucosal vaccines with chitosan adjuvant and meningococcal antigens
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485400A1 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003CA2485262A1 Novel crystalline forms of gatifloxacin
11/20/2003CA2485256A1 Pathogen vaccines and methods for using the same
11/20/2003CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484827A1 Anti-rhinovirus active agents
11/20/2003CA2484736A1 Gallocatechin gallate-containing composition
11/20/2003CA2484704A1 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003CA2484637A1 Nanoparticulate nystatin formulations
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
1 ... 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 ... 1798